Journey Medical Corp (NAS:DERM)

Q1 2026 Journey Medical Corp Earnings Call Transcript

May 13, 2026 / 08:30 PM GMT

Release Date Price: $5.19 (+3.59%)

Transcript 10-Q8-K

Key Points

Positve

Journey Medical Corp (DERM) reported a 21% year-over-year increase in total net product revenues for Q1 2026.
Omrosi revenues grew significantly, reaching $6.3 million, marking a 26% increase from Q4 2025.
The company achieved positive adjusted EBITDA for the quarter, highlighting operational efficiency.
Journey Medical Corp (DERM) secured agreements with the three largest PBM-owned group purchasing organizations, expanding Omrosi's access to 169 million commercial lives.
The refill-to-new prescription ratio for Omrosi improved, indicating strong patient satisfaction and brand loyalty.

Negative

Gross margin decreased to 61% from 63.5% due to a $1.3 million non-cash charge related to inventory write-down.
The company reported a GAAP net loss of $2.2 million for the quarter, although this was an improvement from the previous year.
There is still a reliance on co-pay bridging programs, indicating challenges in achieving full reimbursement.
The company faces seasonality challenges, which could impact prescription volumes during different times of the year.
Despite progress, there is still ongoing work needed to improve Omrosi's tier positioning and quality of coverage with major health plans.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DERM.OQ - Journey Medical Corp
Q1 2026 Journey Medical Corp Earnings Call
May 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2026 Financial Results and Corporate Update Conference Call.

At this time, all participants are on the listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.

Participants of this call advise that the audio of this conference call is being broadcasted live over the Internet and is also being recorded for playback purposes.

A webcast replay of this call will be available approximately one hour after the end of the call for approximately 30 days.

I would now like to turn the call over to Jaclyn Chafe. The company's

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.